The Correlation Between Peripheral Blood Micro-Ribonucleic Acid Expression Level and Personality Disorder in Patients with Schizophrenia.

Honghui Wei, Lingming Kong, Xiaoli Zhu, Shengdong Chen, Liyi Zhang, Wei Niu
Author Information
  1. Honghui Wei: Department of Geriatric Psychiatry, Zhejiang Mental Health Center, Tongde Hospital of Zhejiang Province, Zhejiang, China. ORCID
  2. Lingming Kong: Prevention and Treatment Center for Psychological Diseases, No.904 Hospital of Chinese People's Liberation Army, Jiangsu, China. ORCID
  3. Xiaoli Zhu: Prevention and Treatment Center for Psychological Diseases, No.904 Hospital of Chinese People's Liberation Army, Jiangsu, China. ORCID
  4. Shengdong Chen: Prevention and Treatment Center for Psychological Diseases, No.904 Hospital of Chinese People's Liberation Army, Jiangsu, China. ORCID
  5. Liyi Zhang: Prevention and Treatment Center for Psychological Diseases, No.904 Hospital of Chinese People's Liberation Army, Jiangsu, China. ORCID
  6. Wei Niu: Mental Rehabilitation Center, No.904 Hospital of Chinese People's Liberation Army, Jiangsu, China. ORCID

Abstract

Objective: Schizophrenia patients often have personality disorders; schizophrenia patients with personality disorders are more difficult to treat and have a worse prognosis. Early identification of this group of patients and early intervention can achieve better prognosis. Therefore, it is very important to explore effective biomarkers and early diagnosis for the prognosis of schizophrenia. The primary purpose of this paper is to explore the relationship between plasma miRNA expression level and personality disorder with schizophrenia.
Methods: Gene microarrays in miRNA files were employed, and the plasma of peripheral blood of 82 schizophrenic patients and 43 healthy control subjects were examined. Real-time reverse transcription polymerase chain reaction detection were performed to explore the results. Spearman correlation analysis was used to analyze the correlation between expression level of miRNAs and Personality Diagnosis Questionnaire-4 score.
Results: The results showed that miR-1273d, miR-1303, miR-3064-5p, miR-3131, miR-3687, miR-4428, miR-4725-3p, and miR-5096 were up-regulated in schizophrenic patients. Compared to healthy control subjects, the difference was statistically significant ( < .05). Schizophrenic patients with schizoid, paranoid, schizotypal, and obsessive compulsive traits had negative correlation with miR-1303, miR-3131, miR-4428, and miR-5096 expression level (���=���-0.40 to -0.62, < .05); there were no significant differences in the other miRNAs. Correlation with other personality traits was not significant ( > .05). The stepwise regression analysis indicated that miR-5096, miR-3131, and miR-1273d have a significant predictive effect on the schizoid trait ( < .01). MiR-4428 and miR-1303 had a significant predictive effect on the schizotypal trait ( < .01). MiR-5096, miR-4428, and miR-4725-3P had a significant predictive effect on the paranoid trait ( < .05). MiR-4428, miR-1303, and miR-5096 had a significant predictive effect on the obsessive compulsive trait ( < .05).
Conclusion: The expression levels of miR-1273d, miR-1303, miR-3064-5p, miR-3131, miR-3687, miR-4428, miR-4725-3p, and miR-5096 were up-regulated in the peripheral blood of patients with schizophrenia, and these miRNAs are expected to be diagnostic biomarkers for accurate diagnosis of schizophrenia. The expression levels of miR-1303, miR-3131, miR-1273d, miR-4428, miR-4725-3p, and miR-5096 have significant predictive effects on personality disorder in schizophrenia.

Keywords

References

  1. NPJ Schizophr. 2021 Jul 5;7(1):35 [PMID: 34226568]
  2. Braz J Psychiatry. 2022 Jan-Feb;44(1):74-80 [PMID: 33886948]
  3. Transl Psychiatry. 2019 Nov 11;9(1):289 [PMID: 31712567]
  4. Dis Markers. 2013;35(1):11-21 [PMID: 24167345]
  5. Semin Cell Dev Biol. 2021 Oct;118:83-91 [PMID: 33933350]
  6. J Clin Neurosci. 2015 Mar;22(3):570-4 [PMID: 25487174]
  7. Am J Med Genet B Neuropsychiatr Genet. 2015 Apr;168B(3):170-8 [PMID: 25656957]
  8. Front Neurosci. 2021 Jul 21;15:688727 [PMID: 34366776]
  9. Schizophr Bull. 2018 Oct 17;44(6):1180-1184 [PMID: 29688529]
  10. Radiat Res. 2021 Dec 1;196(6):633-646 [PMID: 34399425]
  11. Int J Mol Sci. 2021 Sep 08;22(18): [PMID: 34575878]
  12. Emerg Microbes Infect. 2018 Sep 19;7(1):155 [PMID: 30228270]
  13. J Neurochem. 2018 Aug;146(3):269-288 [PMID: 29747239]
  14. Prog Mol Biol Transl Sci. 2018;157:21-40 [PMID: 29933951]
  15. Biol Psychiatry. 2020 Apr 15;87(8):736-744 [PMID: 31767120]
  16. Biol Psychiatry. 2006 Jul 1;60(1):40-8 [PMID: 16460694]
  17. Nat Nanotechnol. 2011 Sep 04;6(10):668-74 [PMID: 21892163]
  18. Lancet. 2022 Jan 29;399(10323):473-486 [PMID: 35093231]
  19. Epidemiol Rev. 2008;30:67-76 [PMID: 18480098]
  20. Mol Med Rep. 2020 Aug;22(2):1429-1439 [PMID: 32626976]
  21. Reprod Sci. 2022 Sep;29(9):2685-2696 [PMID: 35503501]
  22. Int J Mol Sci. 2020 Mar 12;21(6): [PMID: 32178454]
  23. Nature. 2014 Jul 24;511(7510):421-7 [PMID: 25056061]
  24. JAMA Psychiatry. 2016 Apr;73(4):369-77 [PMID: 26963595]
  25. Psychiatry Res. 2018 Mar;261:498-503 [PMID: 29395871]
  26. Int J Mol Sci. 2023 Jan 18;24(3): [PMID: 36768211]
  27. Mol Psychiatry. 2020 Dec;25(12):3129-3139 [PMID: 32377000]
  28. Funct Integr Genomics. 2023 Mar 3;23(1):75 [PMID: 36867268]
  29. Hereditas. 2017 Aug 29;155:9 [PMID: 28860957]
  30. J Clin Invest. 2013 Nov;123(11):4557-63 [PMID: 24177465]
  31. Transl Psychiatry. 2019 Aug 20;9(1):196 [PMID: 31431609]
  32. Cells. 2020 Aug 05;9(8): [PMID: 32764320]
  33. Child Adolesc Psychiatr Clin N Am. 2020 Jan;29(1):171-182 [PMID: 31708046]
  34. Clin Neuropsychiatry. 2019 Apr;16(2):86-97 [PMID: 34908942]
  35. Methods. 2010 Apr;50(4):298-301 [PMID: 20146939]
  36. Schizophr Bull. 2019 Sep 11;45(5):1042-1050 [PMID: 30535399]
  37. Psychiatr Genet. 2020 Feb;30(1):1-9 [PMID: 31764709]
  38. Psychiatr Clin North Am. 2020 Jun;43(2):263-274 [PMID: 32439021]
  39. J Biochem Mol Toxicol. 2023 Jun;37(6):e23346 [PMID: 36988443]
  40. Libyan J Med. 2021 Dec;16(1):1909902 [PMID: 33849406]
  41. Curr Treat Options Psychiatry. 2018 Mar;5(1):113-128 [PMID: 30364516]
  42. Lancet. 2009 Aug 22;374(9690):635-45 [PMID: 19700006]
  43. Transl Psychiatry. 2018 Mar 15;8(1):67 [PMID: 29540662]
  44. Cells. 2021 Oct 06;10(10): [PMID: 34685659]
  45. Biol Psychiatry. 2021 Feb 1;89(3):215-226 [PMID: 32381277]

Word Cloud

Created with Highcharts 10.0.0significantpatientsschizophreniapersonalitymiR-1303miR-5096<expressionmiR-3131miR-442805predictivecorrelationmiR-1273deffecttraitprognosisexploremiRNAleveldisordermiRNAsmiR-4725-3pSchizophreniadisordersearlybiomarkersdiagnosisplasmaperipheralbloodschizophrenichealthycontrolsubjectsresultsanalysisPersonalitymiR-3064-5pmiR-3687up-regulatedschizoidparanoidschizotypalobsessivecompulsivetraitsCorrelation01MiR-4428levelsObjective:oftendifficulttreatworseEarlyidentificationgroupinterventioncanachievebetterThereforeimportanteffectiveprimarypurposepaperrelationshipMethods:Genemicroarraysfilesemployed8243examinedReal-timereversetranscriptionpolymerasechainreactiondetectionperformedSpearmanusedanalyzeDiagnosisQuestionnaire-4scoreResults:showedCompareddifferencestatisticallySchizophrenicnegative���=���-040-062differences>stepwiseregressionindicatedMiR-5096miR-4725-3PConclusion:expecteddiagnosticaccurateeffectsPeripheralBloodMicro-RibonucleicAcidExpressionLevelDisorderPatients

Similar Articles

Cited By (1)